KUNGSBACKA, Sweden--(BUSINESS WIRE)--Regulatory News:
Vitrolife (STO:VITR) has obtained approval from Health Canada for a further two new products within the fertility area. The products are used for so-called vitrification, rapid freezing and thawing of cleavage embryos (embryos day 2-3 after fertilization).
